Representatives of AUMED participated in the XL. Congress of Slovak and Czech allergists and clinical immunologists, which took place in Horní Smokovec. AUMED had its own promotional stand at the congress, focused mainly on the immunological preparation TFI. In the form of posters, leaflets and personal interviews, we shared our successes from product development and preclinical studies with the professional public.
The transfer factor-based TFI was a huge success, and many immunologists regretted that the product was not yet registered and could not be prescribed to patients. The entire congress was also very thematically oriented to the issue of transfer factors, including a focus on historical use in our territory.
We believe that AUMED will successfully conduct clinical trials of TFI and soon we will be able to inform medical professionals about the availability of the product on the market.

Read what they wrote about us. In a new article and an interview with our CEO, we discuss our research…
AUMED, a.s. is launching a project titled PhageBiome-N, which has received support under the Operational Programme Technologies and Applications for…
The Beginnings and Establishment of the State Health Institute (SZÚ) AUMED, a.s. is the proud successor to an almost century-long…
Research projects of Aumed, a.s. are financed by the European Structural Funds and with financial support from the state budget through the Ministry of Industry and Trade. A complete list of all ongoing and completed projects with this support can be found here.
European Union
European Regional Development Fund
OP Enterprise and Innovation for Competitiveness